Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia

Diabetes Care

Volumn 23, Issue 2, 2000, Pages 202-207

  Hanefeld, Markolf ^a   Bouter, K Paul ^b   Dickinson, Sheila ^c   Guitard, Christiane ^c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID; NATEGLINIDE; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033985728     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.2.202     Document Type: Article

References (15)

1. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J: Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study. 11-year follow up. Diabetologia 39:1577-1583, 1996
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
3. The DECODE Study Group: Two-hour post-challenge glucose concentrations are belter predictors of mortality than fasting glucose alone: the DECODE Study. Lancet 354:617-621, 1999
4. Barrett-Connor E, Ferrara A: Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men: the Rancho Bernardo Study Diabetes Care 21:1236-1239, 1998
5. Avignon A, Radauceanu A, Monnier L: Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20:1822-1826, 1997
6. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22-29, 1992
7. Shinkai H, Toi K, Kumashiro I, Seto Y, Fukuma M, Dan K, Toyshima S: N-acylphenylalanines and related compounds: a new class of oral hypoglycemic agents. J Med Chem 31:2092-2097, 1988
8. Sato Y, Nishikawa M, Shinkai H, Sukegawa E: Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals. Diabetes Res Clin Pract 12:53-59, 1991
9. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
10. Yalow RS, Berson SA: Plasma insulin concentrations in nondiabetic and in early diabetic subjects: determinations by a new sensitive immuno-assay technique. Diabetes 9:254-260, 1960
11. Groop LC: Sulfonylureas in NIDDM. Diabetes Care 15:737-754, 1992
12. Leclerq-Meyer V, Ladriere L, Fuhlendorff J, Malaisse WJ: Stimulation of insulin and somatostatin release by two meglitinide analogs. Endocrine 7:311-317, 1997
13. Bruttomesso D, Pianta A, Mari A, Valerio A, Marescotti MC, Avogaro A, Tiengo A, Del Prato S: Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetes patients. Diabetes 48:99-105, 1999
14. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kabota M, Kajimoto Y, Kamada T: Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia 38:585-591, 1995
15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997